Christopher T. Ducko, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Surgical Procedures | 1 | 2017 | 341 | 0.450 |
Why?
|
| Community Health Services | 1 | 2017 | 650 | 0.410 |
Why?
|
| Respiratory Paralysis | 1 | 2010 | 31 | 0.370 |
Why?
|
| Ventilator Weaning | 1 | 2010 | 148 | 0.350 |
Why?
|
| Robotics | 8 | 2001 | 892 | 0.340 |
Why?
|
| Quadriplegia | 1 | 2010 | 225 | 0.330 |
Why?
|
| Coronary Artery Bypass | 8 | 2001 | 2281 | 0.310 |
Why?
|
| Academic Medical Centers | 1 | 2017 | 2749 | 0.280 |
Why?
|
| Electrodes, Implanted | 1 | 2010 | 824 | 0.270 |
Why?
|
| Pneumonectomy | 3 | 2021 | 1093 | 0.260 |
Why?
|
| Electric Stimulation Therapy | 1 | 2010 | 605 | 0.250 |
Why?
|
| Pinacidil | 2 | 2000 | 10 | 0.240 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2021 | 5171 | 0.230 |
Why?
|
| Cardioplegic Solutions | 2 | 2000 | 118 | 0.230 |
Why?
|
| Thoracic Surgery, Video-Assisted | 3 | 2015 | 273 | 0.210 |
Why?
|
| Endoscopy | 6 | 2001 | 1774 | 0.200 |
Why?
|
| Lung Neoplasms | 3 | 2021 | 13019 | 0.180 |
Why?
|
| Video-Assisted Surgery | 1 | 2000 | 51 | 0.180 |
Why?
|
| Thoracoscopes | 1 | 1999 | 3 | 0.170 |
Why?
|
| Respiration, Artificial | 1 | 2010 | 2566 | 0.170 |
Why?
|
| Postoperative Complications | 2 | 2021 | 15244 | 0.170 |
Why?
|
| Hospitals, Community | 1 | 2021 | 348 | 0.160 |
Why?
|
| Potassium Channels | 2 | 2000 | 562 | 0.160 |
Why?
|
| Hemolysis | 1 | 1994 | 420 | 0.100 |
Why?
|
| Survival Rate | 3 | 2021 | 12773 | 0.090 |
Why?
|
| Diaphragm | 1 | 2010 | 347 | 0.080 |
Why?
|
| Length of Stay | 2 | 2021 | 6294 | 0.080 |
Why?
|
| Pericardiectomy | 1 | 2008 | 45 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 11001 | 0.070 |
Why?
|
| Calcium Chloride | 3 | 2000 | 77 | 0.070 |
Why?
|
| Potassium Chloride | 3 | 2000 | 238 | 0.070 |
Why?
|
| Pericardial Effusion | 1 | 2008 | 246 | 0.070 |
Why?
|
| Intraoperative Care | 1 | 2009 | 766 | 0.070 |
Why?
|
| Equipment Design | 3 | 2000 | 3582 | 0.060 |
Why?
|
| Bicarbonates | 3 | 2000 | 313 | 0.060 |
Why?
|
| Pacemaker, Artificial | 1 | 2010 | 817 | 0.060 |
Why?
|
| Cattle | 4 | 1999 | 3923 | 0.060 |
Why?
|
| Pleural Neoplasms | 1 | 2009 | 607 | 0.060 |
Why?
|
| Heart-Assist Devices | 1 | 1994 | 1194 | 0.060 |
Why?
|
| Sodium Chloride | 3 | 2000 | 625 | 0.060 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2008 | 1213 | 0.060 |
Why?
|
| Pericardium | 1 | 2008 | 667 | 0.060 |
Why?
|
| Cisplatin | 1 | 2009 | 1637 | 0.060 |
Why?
|
| Mesothelioma | 1 | 2009 | 818 | 0.060 |
Why?
|
| Magnesium | 3 | 2000 | 813 | 0.050 |
Why?
|
| Spinal Cord Injuries | 1 | 2010 | 930 | 0.050 |
Why?
|
| Anastomosis, Surgical | 3 | 2000 | 985 | 0.050 |
Why?
|
| Heart Arrest, Induced | 2 | 2000 | 355 | 0.050 |
Why?
|
| Early Detection of Cancer | 1 | 2015 | 3070 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2021 | 62966 | 0.050 |
Why?
|
| Parabiosis | 1 | 2000 | 65 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2008 | 1581 | 0.050 |
Why?
|
| Coronary Circulation | 3 | 2000 | 1572 | 0.040 |
Why?
|
| Organ Preservation Solutions | 1 | 2000 | 94 | 0.040 |
Why?
|
| Rabbits | 3 | 2000 | 4886 | 0.040 |
Why?
|
| Microsurgery | 3 | 2000 | 796 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2010 | 2121 | 0.040 |
Why?
|
| Cell Size | 1 | 2000 | 643 | 0.040 |
Why?
|
| Organ Preservation | 1 | 2000 | 324 | 0.040 |
Why?
|
| Vascular Patency | 4 | 2001 | 885 | 0.040 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 3800 | 0.040 |
Why?
|
| Male | 12 | 2021 | 349538 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2010 | 3679 | 0.040 |
Why?
|
| Motor Skills | 1 | 2000 | 518 | 0.040 |
Why?
|
| Cold Temperature | 1 | 2000 | 774 | 0.030 |
Why?
|
| Female | 12 | 2021 | 379592 | 0.030 |
Why?
|
| Middle Aged | 7 | 2021 | 213127 | 0.030 |
Why?
|
| Surgical Instruments | 1 | 1999 | 394 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2009 | 13655 | 0.030 |
Why?
|
| Aged | 6 | 2021 | 162944 | 0.030 |
Why?
|
| Myocardial Revascularization | 1 | 1999 | 841 | 0.030 |
Why?
|
| Models, Structural | 1 | 1994 | 361 | 0.030 |
Why?
|
| Humans | 12 | 2021 | 742088 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2021 | 77098 | 0.030 |
Why?
|
| Reperfusion Injury | 1 | 2000 | 1025 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 1999 | 1426 | 0.030 |
Why?
|
| Swine | 2 | 1999 | 5934 | 0.030 |
Why?
|
| Forecasting | 1 | 2000 | 2948 | 0.020 |
Why?
|
| Feasibility Studies | 4 | 2000 | 5062 | 0.020 |
Why?
|
| General Surgery | 1 | 2000 | 1633 | 0.020 |
Why?
|
| Endoscopes | 2 | 1999 | 174 | 0.020 |
Why?
|
| Therapeutic Irrigation | 1 | 2009 | 300 | 0.020 |
Why?
|
| Myocardium | 1 | 2000 | 4775 | 0.020 |
Why?
|
| Animals | 8 | 2000 | 168561 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2000 | 3119 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 56350 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2000 | 7901 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2009 | 1355 | 0.010 |
Why?
|
| Internal Mammary-Coronary Artery Anastomosis | 1 | 2001 | 33 | 0.010 |
Why?
|
| Prognosis | 2 | 2015 | 29010 | 0.010 |
Why?
|
| Time Factors | 3 | 2015 | 40054 | 0.010 |
Why?
|
| Adult | 3 | 2010 | 213712 | 0.010 |
Why?
|
| Tromethamine | 1 | 2000 | 31 | 0.010 |
Why?
|
| Raffinose | 1 | 2000 | 51 | 0.010 |
Why?
|
| Surgical Equipment | 1 | 2000 | 57 | 0.010 |
Why?
|
| Thoracic Arteries | 1 | 2000 | 41 | 0.010 |
Why?
|
| Neoplasms | 1 | 2008 | 21596 | 0.010 |
Why?
|
| Allopurinol | 1 | 2000 | 185 | 0.010 |
Why?
|
| Mammary Arteries | 1 | 1998 | 70 | 0.010 |
Why?
|
| Receptor, erbB-2 | 1 | 2008 | 2410 | 0.010 |
Why?
|
| Glutathione | 1 | 2000 | 586 | 0.010 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1999 | 277 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2009 | 8621 | 0.010 |
Why?
|
| Coronary Angiography | 2 | 1999 | 4567 | 0.010 |
Why?
|
| Pilot Projects | 2 | 2000 | 8297 | 0.010 |
Why?
|
| Evaluation Studies as Topic | 1 | 1998 | 1676 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2015 | 57683 | 0.010 |
Why?
|
| Adenosine | 1 | 2000 | 823 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2008 | 10248 | 0.010 |
Why?
|
| Coronary Disease | 2 | 2000 | 6078 | 0.010 |
Why?
|
| Kidney | 1 | 2009 | 7167 | 0.010 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1998 | 1066 | 0.010 |
Why?
|
| Operating Rooms | 1 | 2000 | 813 | 0.010 |
Why?
|
| Suture Techniques | 1 | 1998 | 797 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 20086 | 0.010 |
Why?
|
| Apoptosis | 1 | 2008 | 9715 | 0.010 |
Why?
|
| United States | 2 | 2015 | 69693 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16665 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2009 | 9185 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 21719 | 0.010 |
Why?
|
| Follow-Up Studies | 2 | 2001 | 39004 | 0.010 |
Why?
|
| Risk Factors | 1 | 2015 | 72145 | 0.010 |
Why?
|
| Glucose | 1 | 2000 | 4391 | 0.000 |
Why?
|
| Acute Disease | 1 | 1998 | 7141 | 0.000 |
Why?
|
| Ventricular Function, Left | 1 | 2000 | 3656 | 0.000 |
Why?
|
| Echocardiography | 1 | 1999 | 5097 | 0.000 |
Why?
|
| Insulin | 1 | 2000 | 6575 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 18006 | 0.000 |
Why?
|
| Prospective Studies | 1 | 2000 | 53187 | 0.000 |
Why?
|